Skip to main content
See every side of every news story
Published • loading... • Updated

BioNTech Q3 revenue down 15% to €1.29B

Summary by BizToc
BioNTech SE announced on Tuesday that its revenue in the third quarter of fiscal 2026 declined 15% year over year to €1.29 billion. The figure did land above market expectations.The pharmaceutical com...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

Mainz – Just a few weeks before the announced departure of co-founders Ugur Sahin and Özlem Türeci, Biontech reported a profit for the third quarter. Nevertheless, a billion loss is due for the first nine months of 2026. According to its own figures, the third quarter closed with a net profit of 184.5 million euros...

(Teleborsa) - BioNTech moves towards a tonic session with the title that rises by more than 2% in the Wall Street pre-market after the accounts beyond expectations and having revised its turnover forecast upwards...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizToc broke the news on Tuesday, November 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal